Annual report pursuant to Section 13 and 15(d)

Cash Equivalents and Marketable Securities

v3.6.0.2
Cash Equivalents and Marketable Securities
12 Months Ended
Dec. 31, 2016
Cash Equivalents and Marketable Securities  
Cash Equivalents and Marketable Securities

3. Cash Equivalents and Marketable Securities

Cash equivalents are highly liquid investments that are readily convertible into cash with original maturities of three months or less when purchased. Marketable securities consist of securities with original maturities greater than 90 days when purchased. The Company classifies these marketable securities as available-for-sale and records them at fair value in the accompanying consolidated balance sheets. Unrealized gains or losses are included in accumulated other comprehensive income (loss). Premiums or discounts from par value are amortized to investment income over the life of the underlying security.

Cash equivalents and marketable securities, available-for-sale, consisted of the following at December 31, 2016 and December 31, 2015 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

Unrealized

 

Fair

 

Description

    

Amortized Cost

    

Gains

    

Losses

    

Value

 

Cash Equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

   Money market funds

 

$

58,588

 

$

 —

 

$

 —

 

$

58,588

 

Marketable Securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

   U.S treasury obligations

 

 

25,014

 

 

 —

 

 

(9)

 

 

25,005

 

Total:

 

$

83,602

 

$

 —

 

$

(9)

 

$

83,593

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

Unrealized

 

Fair

 

Description

    

Amortized Cost

    

Gains

    

Losses

    

Value

 

Money market funds, included in cash equivalents

 

$

35,909

 

$

 —

 

$

 —

 

$

35,909

 

 

Although available to be sold to meet operating needs or otherwise, securities are generally held through maturity. The cost of securities sold is determined based on the specific identification method for purposes of recording realized gains and losses. During the year ended December 31, 2016, there were no realized gains or losses on sales of investments, and no investments were adjusted for other than temporary declines in fair value.

At December 31, 2016, the Company held 10 securities that were in an unrealized loss position.  The aggregate fair value of securities held by the Company in an unrealized loss position for less than twelve months as of December 31, 2016 was $25.0 million and there were no securities held by the Company in an unrealized loss position for more than twelve months. The Company has the intent and ability to hold such securities until recovery. The Company determined that there was no material change in the credit risk of the above marketable securities. As a result, the Company determined it did not hold any marketable securities with an other-than temporary impairment as of December 31, 2016.